| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Investigative Ophthalmology & Visual Science, Vol 38, 283-291, Copyright © 1997 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
G Adamus, M Machnicki and GM Seigel
R.S. Dow Neurological Sciences Institute, Legacy-Good Samaritan Hospital and Medical Center, Portland, Oregon 97209, USA.
PURPOSE: Recoverin has been identified as a target autoantigen for antirecoverin antibodies found in the sera of some patients with cancer- associated retinopathy. The aim of this study was to investigate the role of antirecoverin antibodies in cancer-associated retinopathy. METHODS: Human, rat, and rabbit antirecoverin antibodies were purified using a recoverin-affinity column. Purified biotinylated antibodies were cultured with recoverin-positive rat retinal cells E1A.NR3. Antibody uptake by retinal cells in vitro was analyzed by immunocytochemistry. Cytotoxic effect of antibodies on retinal cells was measured by the MTT colorimetric method. Apoptosis was shown by the ladder DNA fragmentation method and by fluorescent dye chromatin fragmentation analysis. RESULTS: Antirecoverin antibodies obtained either from sera from five cancer-associated retinopathy patients or from sera of immunized animals were internalized by E1A.NR3 cells. Only specific, antirecoverin antibodies produced destruction of the cells in a dose- and time-dependent manner. Normal immunoglobulin G did not have such effects on retinal cells. No additional cell destruction was observed in the presence of complement as compared with cultures incubated with antirecoverin antibodies alone. Internucleosomal DNA fragmentation and presence of apoptotic cells was observed throughout the culture treated with recoverin specific antibodies but not with normal antibodies. Cells not expressing recoverin (Y79, PC12, and GH3) were not susceptible to cell destruction because of antirecoverin antibody action. CONCLUSIONS: These studies showed that antibodies specific to recoverin are able to enter and cause death of cells expressing recoverin. In humans, autoantibodies originally elicited against recoverin expressed in tumor cells may damage retinal photoreceptors and play a role in the pathogenesis of cancer-associated retinopathy. Results suggest that autoantibody to recoverin, when given access to recoverin in the retina through the blood-retina barrier, could initiate photoreceptor degeneration leading to blindness. Such mechanism may be common for other paraneoplastic disorders or autoimmune diseases where antibodies interfere with the normal cell physiology.
This article has been cited by other articles:
|
|
 |
|
  F. Ishikawa, H. Ohguro, I. Ohguro, H. Yamazaki, K. Mamiya, T. Metoki, T. Ito, Y. Yokoi, and M. Nakazawa Prolonged Rhodopsin Phosphorylation in Light-Induced Retinal Degeneration in Rat Models Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5204 - 5211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Kniep, C. Roehlecke, N. Ozkucur, A. Steinberg, F. Reber, L. Knels, and R. H. W. Funk Inhibition of Apoptosis and Reduction of Intracellular pH Decrease in Retinal Neural Cell Cultures by a Blocker of Carbonic Anhydrase. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1185 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Lyons, R. S. Smith, R. E. Hurd, N. L. Hawes, L. M. Burzenski, S. Nusinowitz, M. G. Hasham, B. Chang, and L. D. Shultz Deficiency of SHP-1 Protein-Tyrosine Phosphatase in "Viable Motheaten" Mice Results in Retinal Degeneration. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1201 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jernigan, Y. Morcos, S.M. Lee, F.C. Dohan Jr., C. Raine, and M.C. Levin IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease Neurology, April 22, 2003; 60(8): 1320 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ohguro, K.-i. Ogawa, T. Maeda, I. Maruyama, A. Maeda, Y. Takano, and M. Nakazawa Retinal Dysfunction in Cancer-Associated Retinopathy Is Improved by Ca2+ Antagonist Administration and Dark Adaptation Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2589 - 2595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Hooks, M. O. M. Tso, and B. Detrick Retinopathies Associated with Antiretinal Antibodies Clin. Vaccine Immunol., September 1, 2001; 8(5): 853 - 858. [Full Text] [PDF]
|
|
|
|
|
|
T. Maeda, A. Maeda, I. Maruyama, K.-i. Ogawa, Y. Kuroki, H. Sahara, N. Sato, and H. Ohguro Mechanisms of Photoreceptor Cell Death in Cancer-Associated Retinopathy Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 705 - 712. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Adamus Antirecoverin Antibodies and Autoimmune Retinopathy Arch Ophthalmol, November 1, 2000; 118(11): 1577 - 1578. [Full Text] [PDF]
|
|
|
|
|
|
I. Maruyama, H. Ohguro, and Y. Ikeda Retinal Ganglion Cells Recognized by Serum Autoantibody against {gamma}-Enolase Found in Glaucoma Patients Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1657 - 1665. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Tezel and M. B. Wax The Mechanisms of hsp27 Antibody-Mediated Apoptosis in Retinal Neuronal Cells J. Neurosci., May 15, 2000; 20(10): 3552 - 3562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lei, R. A. Bush, A. H. Milam, and P. A. Sieving Human Melanoma-Associated Retinopathy (MAR) Antibodies Alter the Retinal ON-Response of the Monkey ERG In Vivo Invest. Ophthalmol. Vis. Sci., January 1, 2000; 41(1): 262 - 266. [Abstract] [Full Text]
|
|
|
|
|
|
H. Ohguro, K.-i. Ogawa, T. Maeda, A. Maeda, and I. Maruyama Cancer-Associated Retinopathy Induced by Both Anti-Recoverin and Anti-hsc70 Antibodies In Vivo Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3160 - 3167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Goldstein, N. A. Syed, A. H. Milam, A. M. Maguire, T. J. Lawton, and C. W. Nichols Cancer-Associated Retinopathy Arch Ophthalmol, December 1, 1999; 117(12): 1641 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Maeda, H. Ohguro, T. Maeda, T. Nakagawa, and Y. Kuroki Low Expression of {alpha}A-Crystallins and Rhodopsin Kinase of Photoreceptors in Retinal Dystrophy Rat Invest. Ophthalmol. Vis. Sci., November 1, 1999; 40(12): 2788 - 2794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tezel and M. B. Wax Inhibition of Caspase Activity in Retinal Cell Apoptosis Induced by Various Stimuli In Vitro Invest. Ophthalmol. Vis. Sci., October 1, 1999; 40(11): 2660 - 2667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Wax, G. Tezel, and P. D. Edward Clinical and Ocular Histopathological Findings in a Patient With Normal-Pressure Glaucoma Arch Ophthalmol, August 1, 1998; 116(8): 993 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Adamus, D. Amundson, C. MacKay, and P. Gouras Long-term Persistence of Antirecoverin Antibodies in Endometrial Cancer-Associated Retinopathy Arch Ophthalmol, February 1, 1998; 116(2): 251 - 253. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
